Solvent effect on the synthesis of clarithromycin: A molecular dynamics study
暂无分享,去创建一个
[1] T. Adachi,et al. Chemical modification of erythromycins. IX. Selective methylation at the C-6 hydroxyl group of erythromycin A oxime derivatives and preparation of clarithromycin. , 1993, The Journal of antibiotics.
[2] J. Dannenberg,et al. Effect of Basis Set Superposition Error (BSSE) upon ab Initio Calculations of Organic Transition States , 2001 .
[3] F M Richards,et al. Areas, volumes, packing and protein structure. , 1977, Annual review of biophysics and bioengineering.
[4] C. Baysal,et al. Modeling the selective methylation in the synthesis of clarithromycin , 2002 .
[5] C. Baysal,et al. A computational approach to the synthesis of dirithromycin , 2004, Journal of molecular modeling.
[6] A. Longo,et al. A new convenient transformation of erythromycin A into clarithromycin. , 1999, Bioorganic & medicinal chemistry.
[7] G. van Rooyen,et al. Sensitive liquid chromatography-tandem mass spectrometry method for the determination of clarithromycin in human plasma. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[8] T. Adachi,et al. Chemical modification of erythromycins. XII. A facile synthesis of clarithromycin (6-O-methylerythromycin A) via 2'-silylethers of erythromycin A derivatives. , 1993, The Journal of antibiotics.
[9] F. Schluenzen,et al. Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria , 2001, Nature.
[10] H. Meirovitch,et al. Ab initio prediction of the solution structures and populations of a cyclic pentapeptide in DMSO based on an implicit solvation model , 2000, Biopolymers.
[11] T. Adachi,et al. Chemical modification of erythromycins. II. Synthesis and antibacterial activity of O-alkyl derivatives of erythromycin A. , 1990, The Journal of antibiotics.
[12] Yoshiaki Watanabe,et al. Chemical modification of erythromycins. VIII, A new effective route to clarithromycin (6-O-methylerythromycin A) eng , 1990 .
[13] C. Brooks. Computer simulation of liquids , 1989 .
[14] S. Omura,et al. Chemical modification of erythromycins. III. In vitro and in vivo antibacterial activities of new semisynthetic 6-O-methylerythromycins A, TE-031 (clarithromycin) and TE-032. , 1990, The Journal of antibiotics.
[15] L. Verlet. Computer "Experiments" on Classical Fluids. I. Thermodynamical Properties of Lennard-Jones Molecules , 1967 .
[16] H. C. Andersen. Molecular dynamics simulations at constant pressure and/or temperature , 1980 .
[17] M. Sironi,et al. New basis set superposition error free ab initio MO-VB interaction potential: Molecular-dynamics simulation of water at critical and supercritical conditions , 1998 .
[18] Martin Saunders,et al. Conformations of cycloheptadecane. A comparison of methods for conformational searching , 1990 .
[19] H. Meirovitch,et al. Free energy based populations of interconverting microstates of a cyclic peptide lead to the experimental NMR data. , 1999, Biopolymers.
[20] Michael D. Burkart,et al. Biomimetic synthesis and optimization of cyclic peptide antibiotics , 2002, Nature.
[21] R. Egan,et al. Acid degradation of erythromycin A and erythromycin B , 1971, Experientia.
[22] J. Banavar,et al. Computer Simulation of Liquids , 1988 .
[23] R. Brennan,et al. The conformations of the macrolide antibiotics erythromycin A, azithromycin and clarithromycin in aqueous solution: a 1H NMR study , 2000 .
[24] S. F. Boys,et al. The calculation of small molecular interactions by the differences of separate total energies. Some procedures with reduced errors , 1970 .
[25] Hagai Meirovitch,et al. A free energy based Monte Carlo minimization procedure for biomolecules , 1994 .
[26] P. J. Atkins,et al. Kinetic studies on the decomposition of erythromycin A in aqueous acidic and neutral buffers , 1986 .
[27] D. Osguthorpe,et al. Structure and energetics of ligand binding to proteins: Escherichia coli dihydrofolate reductase‐trimethoprim, a drug‐receptor system , 1988, Proteins.
[28] P. Luger,et al. Molecular structure of 9-deoxy-11-deoxy-9-11-(imino(2-(2-methoxyethoxy)ethylidene)oxy)-(9S)-erythromycin, a new erythromycin derivative , 1979 .
[29] T. Adachi,et al. [Research and development of clarithromycin]. , 1992, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.
[30] Yoshiaki Watanabe,et al. Chemical modification of erythromycins. I. Synthesis and antibacterial activity of 6-O-methylerythromycins A. , 1984, The Journal of antibiotics.